THZ2 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
THZ2

Description

THZ2, an analog of THZ1, with the potential to treat Triple-negative breast cancer (TNBC), it is a potent and selective CDK7 inhibitor which overcomes the instability of THZ1 in vivo.
IC50: CDK7= 13.9 nM; TNBC cells= 10 nM